Keywords: almirall, asthma, drug, shows, strong, results, spain

Almirall asthma drug shows strong results

Article | 02 March 2009

Spain's Almirall has reported new Phase II data demonstrating that its once-daily, inhaled long-acting beta-agonist LAS100977, a treatment for bronchoconstriction ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Almirall

Go to company listing